Ensign Peak Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-79,442	Closed	-$265K	–	1708
2025 Q1	$265K	Sell	79,442 -497,823	-86%	-$2.57M	﹤0.01%	1658
2024 Q4	$4.27M	Buy	577,265 +502,673	+674%	+$4.66M	0.01%	689
2024 Q3	$700K	Hold	74,592	–	–	﹤0.01%	1505
2024 Q2	$598K	Buy	74,592 +8,800	+13%	+$94.3K	﹤0.01%	1553
2024 Q1	$975K	Buy	+65,792	New	+$766K	﹤0.01%	1341
2022 Q4	–	Sell	-251,371	Closed	-$2.41M	–	1992
2022 Q3	$2.41M	Buy	251,371 +104,250	+71%	+$1.2M	0.01%	719
2022 Q2	$1.62M	Buy	147,121 +118,661	+417%	+$1.55M	﹤0.01%	893
2022 Q1	$474K	Sell	28,460 -225,020	-89%	-$3.48M	﹤0.01%	1571
2021 Q4	$4.84M	Buy	253,480 +59,666	+31%	+$1.31M	0.01%	672
2021 Q3	$4.78M	Buy	193,814 +156,909	+425%	+$3.7M	0.01%	676
2021 Q2	$960K	Hold	36,905	–	–	﹤0.01%	1452
2021 Q1	$1.17M	Sell	36,905 -1,460	-4%	-$60.5K	﹤0.01%	1371
2020 Q4	$1.78M	Sell	38,365 -610	-2%	-$24.2K	﹤0.01%	1130
2020 Q3	$1.28M	Buy	38,975 +11,556	+42%	+$354K	﹤0.01%	1193
2020 Q2	$753K	Hold	27,419	–	–	﹤0.01%	1372
2020 Q1	$821K	Buy	27,419 +7,285	+36%	+$193K	﹤0.01%	1243
2019 Q4	$558K	Buy	+20,134	New	+$458K	﹤0.01%	1493